Refractive Error
Conditions
Interventions
Group 1 :Hormone
Group 2:NSAIDs
Group 3:Anti-glaucoma drugs
Sponsors
Qingdao Eye Hospital of Shandong First Medical University
Eligibility
Sex/Gender
All
Age
21 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. The patient underwent corneal refractive surgery for 6 months or more in Qingdao Eye Hospital. 2. Patients must have had a stable refraction for the last 1 months as documented by previous clinical records. 3. Patients aged 21-45 years. 4. Patients must sign a written Informed Consent form. 5. Patients must be able and willing to return for scheduled follow-up examinations for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Patients with eye diseases including secondary keratoconus, dry eye, visual fatigue cause pseudomyopia, glaucoma, cataract, corneal clouding, and retinal disease and systemic diseases. 2. Patients missed any follow-up visits within the first three months after surgery. 3. Patients experienced uncontrolled steroid-induced ocular hypertension occurred during postoperative topical corticosteroid administration. 4. Patients who have a known sensitivity to study medication. 5. Women who are pregnant, lactating, or planning to become pregnant over the course of this clinical investigation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corneal epithelial thickness;Corneal topography;Naked eyes and corrected vision;Refractive power;Optical area;Corneal curvature;Intraocular pressure;Biomechanical parameters;Posterior corneal elevation;Ablation depth; | — |
Countries
China
Contacts
Public ContactLong Keli
Qingdao Eye Hospital of Shandong First Medical University
Outcome results
None listed